🕵️ Aurinia Pharmaceuticals Inc. ($AUPH)
SEC insider & ownership activity, last 12 months · CIK 1600620 · every row links its SEC filing
Over the last 12 months insiders sold $210K against $38.7M of open-market buying. Tang Kevin bought $38.7M (Aug–Jun). 1 planned sale is pending, the largest $54.1M (Gregory Keenan). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $38.7M (14 lots) · 1 seller, $210K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Tang Kevin | 14 | $38.7M | 0 | – | Jun 2, 2026 |
| Gregory Keenan | 0 | – | 1 | $210K | Aug 1, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Kevin Tang | 10.0% | 13D | Jun 2, 2026 | filing ↗ | |
| TANG Capital Management, LLC | 10.0% | 13D | Jun 2, 2026 | filing ↗ | |
| TANG Capital Partners, LP | 5.6% | 13D | Jun 2, 2026 | filing ↗ | |
| Chin Kyu Huh | 5.0% | 13D | Aug 11, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Gregory Keenan | $158K | Jun 5, 2026 | filing ↗ |
| Gregory Keenan | $408K | Jun 4, 2026 | filing ↗ |
| Gregory Keenan | $54.1M | Jun 2, 2026 | filing ↗ |
| Peter Greenleaf | $49.7M | May 11, 2026 | filing ↗ |
| Matthew Maxwell Donley | $11.4M | May 11, 2026 | filing ↗ |
| Joseph Miller | $7.9M | May 11, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | May 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 8, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 20, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Earnings (2.02) | Jul 31, 2025 | filing ↗ |
| Other events (8.01) | Jul 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2025 | filing ↗ |